Your position:m.limatoxi.com>>EN>>EN>>Veterinary Drug>>Steroid hormone intermediate enterprises:Saito Bio achieved an operating income of 913 million yuan in 2020>> article
Steroid hormone intermediate enterprises:Saito Bio achieved an operating income of 913 million yuan in 2020
Editor:xuezhe Clicks:0Date:2021-4-20 15:10:30
Keyword:Steroid hormone intermediate
Healthoo Information:
Saito Bio achieved an operating income of 913 million yuan in 2020
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • Yuyang is building Rosuvastatin intermediate project
  • Wonder reconstructs steroid hormone production lines
  • Keyixin hormone APIs project into production
  • Xinquan to build cephalosporin intermediates project
  • FST Oseltamivir intermediate sales value
  • Kaitai to build steroid hormone project
  • Huaxin to build APIs & intermediates project
  • Xianju 9 hormone APIs passed GMP inspection
  • Antibiotic intermediates increased
  • Junye steroid hormone project passed acceptance check
    		•
    Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map